Renal effects of endothelin in anesthetized rabbits

European Journal of Pharmacology

Volumn 359, Issue 2-3, 1998, Pages 177-184

  Ono, Naoto ^a   Matsui, Toshiyuki ^a   Yoshida, Makoto ^a   Suzuki Kusaba, Mizue ^a   Hisa, Hiroaki ^a   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Endothelin ET(A) receptor; Endothelin ET(B) receptor; Endothelin 1; Kidney; Nitric oxide (NO); Rabbit

Indexed keywords

1 HYDROXY 2 OXO 3 (N METHYL 3 AMINOPROPYL) 3 METHYL 1 TRIAZENE; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SODIUM URINE LEVEL; URINE FLOW RATE;

ANALYSIS OF VARIANCE; ANESTHESIA; ANIMALS; AZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HYDRAZINES; INDOLES; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; OLIGOPEPTIDES; PIPERIDINES; RABBITS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; SODIUM; URINATION;

EID: 0031731496     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00647-5     Document Type: Article

References (34)

1. ω-nitro-L-arginine methyl ester and losartan. Eur. J. Pharmacol. 308:1996;165-171.
2. Adachi Y., Hashimoto K., Ono N., Yoshida M., Suzuki-Kusaba M., Hisa H., Satoh S. Renal effects of a nitric oxide donor, NOC 7, in anesthetized rabbits. Eur. J. Pharmacol. 324:1997;223-226.
3. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 8:1994;436-439.
4. + transport in the cultured renal epithelial cell line, LLC-PK1. Biochem. Biophys. Res. Commun. 134:1986;852-860.
5. Clavell A.L., Stingo A.J., Margulies K.B., Brandt R.R., Burnett J.C. Jr. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am. J. Physiol. 268:1995;F455-F460.
6. Cristol, J-P., Warner, T.D., Thiemermann, C., Vane, J.R., 1993. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat, 108, 776-779.
7. B receptor antagonists in the rabbit in vivo and in vitro. J. Cardiovasc. Pharmacol. 26(Suppl. 3):1995;S369-S372.
8. Fitzgerald S.M., Evans R.G., Christy I.J., Anderson W.P. Nitric oxide synthase blockade and renal vascular responses to norepinephrine and endothelin-1 in conscious dogs. J. Cardiovasc. Pharmacol. 25:1995;979-985.
9. + ATPase activity in the rat proximal straight tubule. J. Am. Soc. Nephrol. 2:1991;976-982.
10. Goetz K.L., Wang B.C., Madwed J.B. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255:1988;R1064-R1068.
11. Hirata Y., Matsuoka H., Kimura K., Sugimoto T., Hayakawa H., Suzuki E., Sugimoto T. Role of endothelium-derived relaxing factor in endothelin-induced renal vasoconstriction. J. Cardiovasc. Pharmacol. 17(Suppl. 7):1991;S169-S171.
12. Hirata Y., Hayakawa H., Suzuki E., Kimura K., Kikuchi K., Nagano T., Hirobe M., Omata M. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation. 91:1995;1229-1235.
13. Ishii K., Warner T.D., Sheng H., Murad F. Endothelin increases cyclic GMP levels in LLC-PK1 Porcine kidney epithelial cells via formation of an endothelium-derived relaxing factor-like substance. J. Pharmacol. Exp. Ther. 259:1991;1102-1108.
14. King A.J., Brenner B.M., Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256:1989;F1051-F1058.
15. Kitamura K., Tanaka T., Kato J., Ogawa T., Eto T., Tanaka K. Immunoreactive endothelin in rat kidney inner medulla: marked decrease in spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 162:1989;38-44.
16. Kon V., Badr K.F. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int. 40:1991;1-12.
17. Lerman, A., Sandok, E.K., Hildebrand Jr., F.R., Burnett Jr., J.C., 1992. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction, 85, 1894-1898.
18. MacCumber M.W., Ross C.A., Glaser B.M., Snyder S.H. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. USA. 86:1989;7285-7289.
19. Majid D.S.A., Williams A., Navar L.G. Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs. Am. J. Physiol. 264:1993;F79-F87.
20. Marsden P.A., Dorfman D.M., Collins T., Brenner B.M., Orkin S.H., Ballermann B.J. Regulated expression of endothelin-1 in glomerular capillary endothelial cells. Am. J. Physiol. 261:1991;F117-F125.
21. Matsumura Y., Hisaki K., Ohyama T., Hayashi K., Morimoto S. Effects of endothelin on renal function and renin secretion in anesthetized rats. Eur. J. Pharmacol. 166:1989;577-580.
22. B-receptor agonist, in anesthetized rats. Jpn. J. Pharmacol. 71:1996;213-222.
23. Miller W.L., Redfield M.M., Burnett J.C. Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83:1989;317-320.
24. + transport by atriopeptin, protein kinase C, and pertussis toxin. Am. J. Physiol. 253:1987;F372-F376.
25. Munger K.A., Sugiura M., Takahashi K., Inagami T., Badr K.F. A role for atrial natriuretic peptide in endothelin-induced natriuresis. J. Am. Soc. Nephrol. 1:1991;1278-1283.
26. Ono N., Adachi Y., Hashimoto K., Yoshida M., Suzuki-Kusaba M., Hisa H., Satoh S. A nitric oxide donor NOC 7 suppresses renal responses induced by norepinephrine and angiotensin II in the NO-depleted denevated rabbit kidney. Eur. J. Pharmacol. 342:1998;285-289.
27. B receptors couple to two distinct signalling pathways in porcine kidney epithelial LLC-PK1 cells. J. Pharmacol. Exp. Ther. 270:1994;1035-1040.
28. Scavone C., Scanlon C., McKee M., Nathanson J.A. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J. Pharmacol. Exp. Ther. 272:1995;1036-1043.
29. Shichiri M., Hirata Y., Emori T., Ohta K., Nakajima T., Sato K., Sato A., Marumo F. Secretion of endothelin and related peptides from renal epithelial cell lines. FEBS Lett. 253:1989;203-206.
30. Takagi H., Takahara A., Tomura Y., Yamagata T., Hisa H., Satoh S. Effects of nifedipine, 8-(N, N-diethylamino) octyl-3, 4, 5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriures in dogs. J. Pharmacol. Exp. Ther. 267:1993;456-461.
31. Tolins J.P., Palmer R.M.J., Moncada S., Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 258:1990;H655-H662.
32. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
33. B receptor agonist, IRL1620. Eur. J. Pharmacol. 264:1994;399-405.
34. +-ATPase in intact renal tubular epithelial cells. Am. J. Physiol. 257:1989;C1101-C1107.